New treatment options for patients with brain metastases from ovarian cancer
Brain metastases from ovarian cancer are quite rare: they affect no more than 0.5–3.0 % of patients according to the literature. However, the incidence of brain metastasis is increasing, which is attributed to longer survival of ovarian cancer patients and more accurate diagnosis. It is not possible...
Main Authors: | A. G. Kedrova, S. E. Krasilnikov, A. G. Vinokurov, A. I. Berishvili, T. A. Greyan, O. P. Krashenkov, E. S. Polovnikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2021-10-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/870 |
Similar Items
-
Treatment of patients with brain metastases from ovarian cancer: clinical observation
by: V. B. Karakhan, et al.
Published: (2014-08-01) -
Role of poly-ADP-ribose polymerase inhibitors after brain progression in platinum-sensitive ovarian cancer: a case report and review of the literature
by: Gonzalo Lendinez-Sanchez, et al.
Published: (2024-08-01) -
Supraclavicular metastases from ovarian cancer
by: Nicolae Bacalbasa, et al.
Published: (2023-06-01) -
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers
by: Gloria Mittica, et al.
Published: (2020-05-01) -
OVARIAN CANCER WITH SOLITARY BRAIN METASTASIS. A CLINICAL CASE OF PROLONGED (OVER 7 YEARS) COMPLETE REMISSION AFTER COMBINED TREATMENT
by: N. V. Sevyan, et al.
Published: (2018-04-01)